Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Misonix Inc. (MSON) -- Ignore unavailable to you. Want to Upgrade?

To: Candle stick who wrote (850)	12/13/1998 11:43:00 PM
From: Kailash	Respond to of 947

Hi Candle - Do you have a link to some more info on this trial? The company looks great so what's the problem? K

To: Candle stick who wrote (850)	12/16/1998 11:55:00 AM
From: Beltropolis Boy	Read Replies (1) \| Respond to of 947

Excerpted from DEF 14A filed on 12/11 by MISONIX INC: MISONIX INC files annual meeting proxy NOTICE OF ANNUAL MEETING OF SHAREHOLDERS January 13, 1999 Common Shares Percent Name and Address(1) Beneficially Owned of Class Howard Alliger 909,108 (2) 15.6% Joseph Librizzi (3) 247,700 (4) 4.2% Gary Gelman 750,750 (5) 11.6% Arthur Gerstenfeld 56,200 (6) * Michael A. McManus, Jr. 145,700 (7) 2.5% All executive officers and 2,283,853 (8) 33.1 (9) Directors as a group (eight persons) *Less than 1% (1) The business address of each of the named individuals in this table is c/o MISONIX, INC., 1938 New Highway, Farmingdale, New York 11735. (2) Includes 75,000 Common Shares which Mr. Alliger has the right to acquire upon exercise of stock options which are currently exercisable. (3) Mr. Librizzi is not standing for reelection as a Director. His Employment Agreement with the Company was extended to, and expired on, October 30, 1998 and he will act as an independent consultant for the Company for the six months ending April, 1999. (4) Includes 110,000 Common Shares which Dr. Librizzi has the right to acquire upon exercise of stock options which are currently exercisable. (5) Includes 688,500 Common Shares which Mr. Gelman has the right to acquire upon exercise of stock options which are currently exercisable. (6) Includes 18,000 Common Shares which Mr. Gerstenfeld has the right to acquire upon exercise of stock options which are currently exercisable. (7) Includes 125,000 Common Shares which Mr. McManus has the right to acquire upon exercise of stock options which are currently exercisable. (8) Includes the Common Shares indicated in notes (2), (4), (5), (6) and (7), 85,395 Common Shares which are beneficially owned by an executive officer of the Company (32,500 of which he has the right to acquire upon exercise of stock options which are currently exercisable), 56,500 Common Shares which are beneficially owned by another executive officer of the Company (55,000 of which he has the right to acquire upon exercise of stock options which are currently exercisable) and 32,500 Common Shares which another executive officer has the right to acquire upon exercise of stock options which are currently exercisable. (9) Based upon 5,767,680 outstanding Common Shares and presently exercisable options to acquire 1,136,500 Common Shares held by the persons noted. sec.gov